TUBERCULOSIS
Clinical trials for TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nursing boost aims to curb TB dropout crisis
Disease control Not yet recruitingThis study tests whether extra nursing care, both in the hospital and at home, can help people with tuberculosis stick with their treatment. Many patients stop treatment early, which can lead to relapse and spread of the disease. The study will enroll 40 adults and track how many…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 07:32 UTC
-
New 9-Month pill regimen could transform Drug-Resistant TB care
Disease control Not yet recruitingThis study tests a 9-month, all-oral drug combination (BLMZ) for people with rifampicin-resistant tuberculosis. About 120 participants aged 12 and older will take the pills and be monitored for 24 months. The goal is to see if this shorter treatment works well and is safe for Chi…
Matched conditions: TUBERCULOSIS
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated May 26, 2026 07:28 UTC
-
Personalized TB treatment could shorten recovery time
Disease control Not yet recruitingThis study tests whether tuberculosis (TB) treatment can be personalized based on a person's risk of poor outcomes. About 900 adults with drug-sensitive TB will be grouped as lower-risk or higher-risk. Lower-risk participants may get a shorter treatment, while higher-risk partici…
Matched conditions: TUBERCULOSIS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New combo therapy aims to slash sepsis deaths in HIV patients
Disease control Not yet recruitingThis study tests whether adding a steroid (hydrocortisone) and a powerful antibiotic combination to standard care can help more people with HIV survive sepsis, a life-threatening infection reaction. About 344 adults in Africa will take part. The goal is to find a better treatment…
Matched conditions: TUBERCULOSIS
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New biopsy technique may improve TB diagnosis in lymph nodes
Diagnosis Not yet recruitingThis study tests a newer biopsy method (EBUS-TBMC) against a standard one (EBUS-TBNA) for diagnosing tuberculosis in the lymph nodes of the chest. About 108 adults with suspected TB will have both procedures during the same visit. The goal is to see which method finds TB more acc…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Diagnosis
Last updated May 26, 2026 07:27 UTC
-
New TB tests aim to find thousands of hidden cases in indonesia
Diagnosis Not yet recruitingThis study tests whether new, easier-to-use diagnostic tests can help find more tuberculosis (TB) cases in Indonesia. About 40,000 people with TB symptoms will take part. The goal is to see if these tests lead to more people being diagnosed and treated sooner.
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Universitas Padjadjaran • Aim: Diagnosis
Last updated May 26, 2026 07:22 UTC
-
Can bringing TB prevention home save more kids?
Prevention Not yet recruitingThis study tests whether having health workers visit families at home can help more children under 15 start and finish tuberculosis (TB) prevention treatment compared to the usual clinic visits. About 1,300 children in southern Ethiopia will take part. The goal is to find a bette…
Matched conditions: TUBERCULOSIS
Phase: NA • Sponsor: Dilla University • Aim: Prevention
Last updated May 26, 2026 07:22 UTC
-
New study aims to protect kids from TB with shorter daily treatment
Prevention Not yet recruitingThis study is testing a 28-day daily treatment (rifapentine plus isoniazid) to prevent tuberculosis (TB) in children under 13 years old, including those with HIV. About 144 children will take part, split into two groups based on HIV status. The goal is to find the best dose and e…
Matched conditions: TUBERCULOSIS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated May 18, 2026 12:01 UTC
-
New rapid TB test could predict treatment success in kenya
Knowledge-focused Not yet recruitingThis study will test a new rapid test called PATHFAST TB LAM to see if it can help monitor treatment for tuberculosis (TB). Researchers will follow 300 adults in Nairobi, Kenya, during their 6-month TB treatment, collecting sputum and urine samples at regular visits. The goal is …
Matched conditions: TUBERCULOSIS
Sponsor: Nagasaki University • Aim: Knowledge-focused
Last updated May 26, 2026 07:29 UTC
-
Blood test study aims to unlock secrets of lung disease
Knowledge-focused Not yet recruitingThis study looks at how the immune system works in people with lung diseases like asthma, COPD, pneumonia, and tuberculosis. Researchers will analyze a single blood sample from 100 adults to see how certain immune cells respond to inflammation and infection. Participants won't re…
Matched conditions: TUBERCULOSIS
Sponsor: Research Center Borstel • Aim: Knowledge-focused
Last updated May 26, 2026 07:21 UTC
-
New TB risk score could cut unnecessary isolation in hospitals
Knowledge-focused Not yet recruitingThis study aims to collect information from 686 people with confirmed or suspected tuberculosis at a hospital in Italy. Researchers will use this data to create a simple risk score that helps doctors quickly decide who needs to be isolated and who does not. The goal is to improve…
Matched conditions: TUBERCULOSIS
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC